IL17A and irritable bowel syndrome: Taken together, these results suggest that Vδ1 γδ T cells was the predominant γδ T cells in both peripheral and intestinal tissue and was the major IL-17 producing γδ T cells in PI-IBS, which would be a novel therapeutic target for PI-IBS.